MANUEL COBO DOLS – ENSAYO CLÍNICO CON MEDICAMENTOS – MERCK HEALTHCARE KGAA
An Open label, Multicenter, Phase 1b/2a Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacokinetics of the M1774 in Combination with Cemiplimab in Participants with Non-Squamous Non-Small Cell Lung Cancer that has Progressed on Prior Anti-PD-(L)1 and Platinum-based Therapies (DDRiver NSCLC 322)
por prodriguez | Jul 3, 2024 | Ensayos Clínicos, Ensayos Clínicos - CIMO-02 | 0 Comentarios